Skip to content
CheckOrphan
  • Home
  • About Us
  • Log In
  • News
    • All News
    • Finance
    • Treatment
    • People
    • Research
  • Videos
  • Treatments
  • Clinical Trials
  • Access Programs
    • About Access Programs
  • Diseases
  • Events
  • Networks
  • Research
Main Menu

Subscribe for Free Newsletter

Email *

Type *

* Required Field
Email Marketing Services by Benchmark

Generate RSS

  1. Home
  2. /
  3. Clinical Trial
  4. /
  5. Everolimus Trial in Laryngotracheal...

Everolimus Trial in Laryngotracheal Stenosis

December 11, 2021checkorphan
Learn more about:
Idiopathic subglottic tracheal stenosis
Related Clinical Trial
Effects of Interleukin (IL)-17A Inhibition on Idiopathic Subglottic Stenosis Everolimus Trial in Laryngotracheal Stenosis

Recruitment Information

Administrative Informations

Related Clinical Trial

  • Effects of Interleukin (IL)-17A Inhibition on Idiopathic Subglottic St
More Clinical Trial

Related

  • Effects of Interleukin (IL)-17A Inhibition on Idiopathic Subglottic St
  • Idiopathic subglottic tracheal stenosis
More
pw

About CheckOrphan

CheckOrphan is a non-profit organization located in Basel, Switzerland and Santa Cruz, California that is dedicated to rare, orphan and neglected diseases. CheckOrphan offers users an interactive and dynamic platform for all these diseases. This strategy allows visitors to be updated daily on all the latest news and interact with people internationally. This is essential, because due to the nature of these diseases, there is not a large concentration of individuals within any given proximity.
Click here to know more About Us

Your email is important to us

Each email is sent to a CheckOrphan staff member and will be answered. We only use a contact form to avoid spam.

    Copyright © 2024 CheckOrphan.
    Developed by: Gonza.io logo Developed by: WebOptimalSolutions Powered by: Cloudscale logo